Categories: Health

UK becomes first country to approve Merck pill to kill COVID-19

<p>
Britain on Thursday became the first country in the world to approve a potentially game-changing antiviral pill to treat COVID-19, jointly developed by U.S. pharma companies Merck and Ridgeback Biotherapeutics.</p>
<p>
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, be used as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms.</p>
<p>
The tablet will be given twice a day for five days to vulnerable patients recently diagnosed with the disease.</p>
<p>
In clinical trials the pill, originally developed to treat flu, cut the risk of hospitalisation or death by about half.</p>
<p>
It is the first antiviral medication for Covid which can be taken as a pill rather than injected or given intravenously.</p>
<p>
The UK has agreed to purchase 480,000 courses with the first deliveries expected in November, according to a BBC report.</p>
<p>
It cited UK Health Secretary Sajid Javid as saying the treatment was a "gamechanger" for the most frail and immunosuppressed.</p>
<p>
In a statement he said: "Today is a historic day for our country, as the UK is now the first country in the world to approve an antiviral that can be taken at home for Covid."</p>
<p>
This is the first oral antiviral treatment for COVID-19 to get approved, with the approval coming ahead of potential U.S. regulatory clearance. U.S. advisers will meet this month to vote on whether molnupiravir should be authorized.</p>
<p>
The drug, to be branded Lagevrio in Britain, is designed to introduce errors into the genetic code of the virus that causes COVID-19.</p>
<p>
The speedy approval in Britain comes as the country has about 40,000 daily cases of COVID-19, according to the latest seven-day average. That total is second only to the roughly 74,000 a day in the United States, which has a five times larger population.</p>
<p>
<strong>Also read: <a href="https://www.indianarrative.com/health-news/who-approves-india-s-homegrown-vaccine-covaxin-for-emergency-use-125864.html">WHO approves India’s homegrown vaccine Covaxin for emergency use</a></strong></p>

IN Bureau

Recent Posts

Uganda gears up to roll out Aadhaar-like ID system, eyes UPI adoption

By Vishu Adhana Uganda is set to roll out an Aadhaar-like digital identification system based…

1 hour ago

Tibet activists demand full investigation following suspicious death of Tibetan leader in Vietnam

Global Tibet advocacy groups have voiced serious concern and are urging a full and transparent…

1 hour ago

BYC calls for mass demonstrations against state crackdown across Balochistan

A wave of protest demonstrations and sit-ins is set to sweep across Balochistan on Sunday,…

2 hours ago

“Operations will go on until terrorists are eliminated”: Army on ongoing encounter with terrorists in J-K

Amid the ongoing operations and terrorist attacks in Jammu and Kashmir, the Indian Army on…

4 hours ago

“EU has tools to respond to trade war, preparing toolbox for several months”: Carnegie Europe Director Rosa Balfour

Carnegie Europe Director Rosa Balfour said that the European Union has the tools to respond…

4 hours ago

India highlights BioE3 Policy at Mission Innovation Annual Gathering 2025 in Seoul

The Department of Biotechnology (DBT) co-leads the Mission Integrated Biorefinery jointly with the Netherlands as…

6 hours ago